Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS CoV 2 Vaccination”

21 trials

Showing 20 of 21 results

Not applicableWithdrawnNCT04854876
What this trial is testing

Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19

Who this might be right for
SARS-COV 2Covid19
Royal College of Surgeons in Ireland - Medical University of Bahrain
Not applicableStudy completedNCT04970550
What this trial is testing

Vaccination Against SARS-Cov2 (COVID-19) in Chronic Inflammatory Rheumatism and Factors Determining Its Decision.

Who this might be right for
Rheumatoid ArthritisSpondyloarthritis
Hopital Nord Franche-Comte 150
Not applicableStudy completedNCT05244343
What this trial is testing

I VACCIN Hospitalization of COVID-19 Patients

Who this might be right for
SARS CoV 2 InfectionCOVID-19
Eshmoun Clinical Research Center 1,096
Not applicableStudy completedNCT06503926
What this trial is testing

Impact of COVID-19 Vaccination on Balance Function Among Adolescents: A Long-Term Perspective

Who this might be right for
SARS CoV 2 Vaccination
Sinai University 270
Not applicableLooking for participantsNCT05973084
What this trial is testing

COVID-19 Transmission and Morbidity in Malawi

Who this might be right for
SARS CoV 2 InfectionSARS CoV 2 Vaccination
Boston University 1,500
Not applicableUnknownNCT05960058
What this trial is testing

Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Systemic SclerosisSARS-CoV 2 Vaccination
Assistance Publique - Hôpitaux de Paris 72
Large-scale testing (Phase 3)UnknownNCT04891172
What this trial is testing

Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

Who this might be right for
Covid19
Dow University of Health Sciences 310
Post-approval studies (Phase 4)Study completedNCT06360744
What this trial is testing

A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.

Who this might be right for
SARS CoV 2 Infection
Jens D Lundgren, MD 25
Large-scale testing (Phase 3)Study completedNCT05715944
What this trial is testing

Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2

Who this might be right for
COVID-19
Botswana Harvard AIDS Institute Partnership 10,888
Not applicableUnknownNCT04747522
What this trial is testing

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)

Who this might be right for
Kidney Transplant InfectionSARS-CoV Infection
Oslo University Hospital 150
Not applicableStudy completedNCT05222139
What this trial is testing

Monitoring COVID-19 Vaccination Response in Fragile Populations

Who this might be right for
SARS CoV 2 InfectionVaccination; InfectionBreakthrough Infection
University of Bologna 8,894
Not applicableUnknownNCT05547451
What this trial is testing

SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis

Who this might be right for
SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis
Nantes University Hospital 200
Not applicableStudy completedNCT04934215
What this trial is testing

Evaluation of Post-vaccination Anti-SARS-CoV-2 Serological Response in Health Care Workers With a History of COVID-19.

Who this might be right for
SARS CoV 2 InfectionVaccination Reaction
Fondation Hôpital Saint-Joseph 73
Not applicableUnknownNCT05153044
What this trial is testing

Severe Acute Respiratory Syndrome CoV 2 COVID-19 Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-France

Who this might be right for
Sickle Cell Disease
Assistance Publique - Hôpitaux de Paris 880
Not applicableUnknownNCT06435403
What this trial is testing

SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia

Who this might be right for
SARS CoV 2 InfectionCOVID-19 BreakthroughCOVID-19 Recurrent
Michael Hoelscher 1,000
Not applicableStudy completedNCT06191341
What this trial is testing

Consequences in ICU of Vaccination Status of Covid-19 Patients

Who this might be right for
SARS CoV 2 Infection
Centre Hospitalier Régional Metz-Thionville 1,058
Early research (Phase 1)Study completedNCT05260437
What this trial is testing

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

Who this might be right for
COVID-19SARS-CoV-2
GlaxoSmithKline 99
Not applicableUnknownNCT04347694
What this trial is testing

Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.

Who this might be right for
SARS-CoV 2Immunization; Infection
Medical University of Vienna 400
Not applicableActive Not RecruitingNCT04853004
What this trial is testing

Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations

Who this might be right for
SARS-CoV 2
Karolinska Institutet 10,000
Large-scale testing (Phase 3)Study completedNCT05303402
What this trial is testing

A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.

Who this might be right for
SARS CoV 2 Infection
Hipra Scientific, S.L.U 241
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation